Piramal Life Sciences trading at Rs 500
Piramal Life Sciences, the demerged drug research company of Nicholas Piramal, listed at Rs 391 on the NSE on Thursday. At 10:39 am, the share was trading at Rs 500.
By ET Online |
MUMBAI: Piramal Life Sciences, the demerged drug research company of Nicholas Piramal, listed at Rs 391 on the NSE on Thursday. At 10:39 am, the share was trading at Rs 500.
It touched a high of Rs 519 and low of Rs 101.10 on volume of 15,16,374 shares.
The company had issued 1 share of Piramal Life Sciences for every 10 of the parent company. The new company will focus on research work in treating cancer, diabetes, inflammation and infectious diseases.
On the BSE, the stock opened at Rs 300 and was trading at Rs 494.50. Total number of 1349530 shares were traded in the counter.
It touched a high of Rs 519 and low of Rs 101.10 on volume of 15,16,374 shares.
The company had issued 1 share of Piramal Life Sciences for every 10 of the parent company. The new company will focus on research work in treating cancer, diabetes, inflammation and infectious diseases.
On the BSE, the stock opened at Rs 300 and was trading at Rs 494.50. Total number of 1349530 shares were traded in the counter.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
